Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.05)
# 1,211
Out of 4,835 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $6.24 | +76.28% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.60 | +435.71% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $4.06 | +294.09% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $7.46 | +3,921.45% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $98.23 | -13.47% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $27.96 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $135.74 | +271.30% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $7.13 | +5,369.85% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $8.83 | -9.40% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $7.52 | +1,828.19% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $4.42 | +4,085.52% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $320.94 | -20.55% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $237.96 | +68.10% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $25.40 | +25.98% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $61.78 | +33.54% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $6.24
Upside: +76.28%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.60
Upside: +435.71%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $4.06
Upside: +294.09%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $7.46
Upside: +3,921.45%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $98.23
Upside: -13.47%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $27.96
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $135.74
Upside: +271.30%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $7.13
Upside: +5,369.85%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $8.83
Upside: -9.40%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $7.52
Upside: +1,828.19%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $4.42
Upside: +4,085.52%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $320.94
Upside: -20.55%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $237.96
Upside: +68.10%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $25.40
Upside: +25.98%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $61.78
Upside: +33.54%